BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17509106)

  • 21. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion.
    Dhodapkar M; Goldberg SL; Tefferi A; Gertz MA
    Am J Hematol; 1994 Feb; 45(2):187-8. PubMed ID: 7908165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells.
    Maral S; Albayrak M; Pala C; Yildiz A; Sahin O; Ozturk HB
    Cell Tissue Bank; 2018 Dec; 19(4):831-832. PubMed ID: 30099684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular toxicity of cryopreserved cord blood cell infusion.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kobayashi T; Sato A; Kato S; Kasahara S; Ebihara Y; Nagamura-Inoue T; Tsuji K; Tojo A; Asano S
    Bone Marrow Transplant; 2008 May; 41(10):861-5. PubMed ID: 18209718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
    Marcacci G; Corazzelli G; Becchimanzi C; Arcamone M; Capobianco G; Russo F; Frigeri F; Pinto A
    Bone Marrow Transplant; 2009 Jul; 44(2):133-5. PubMed ID: 19182835
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation.
    Windrum P; Morris TC
    Bone Marrow Transplant; 2003 Feb; 31(4):315. PubMed ID: 12621472
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion.
    Bauwens D; Hantson P; Laterre PF; Michaux L; Latinne D; De Tourtchaninoff M; Cosnard G; Hernalsteen D
    Leuk Lymphoma; 2005 Nov; 46(11):1671-4. PubMed ID: 16236621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryopreservation with hydroxyethylstarch (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone.
    Clapisson G; Salinas C; Malacher P; Michallet M; Philip I; Philip T
    Bull Cancer; 2004 Apr; 91(4):E97-102. PubMed ID: 15562559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
    Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
    Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
    Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
    Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
    Ferrara F; Mele G; Palmieri S; Pedata M; Copia C; Riccardi C; Izzo T; Criscuolo C; Musto P
    Hematol Oncol; 2009 Dec; 27(4):198-202. PubMed ID: 19475701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.
    Zenhäusern R; Tobler A; Leoncini L; Hess OM; Ferrari P
    Ann Hematol; 2000 Sep; 79(9):523-6. PubMed ID: 11043425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
    Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
    Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature.
    Ruiz-Delgado GJ; Mancías-Guerra C; Tamez-Gómez EL; Rodríguez-Romo LN; López-Otero A; Hernández-Arizpe A; Gómez-Almaguer D; Ruiz-Argüelles GJ
    Acta Haematol; 2009; 122(1):1-5. PubMed ID: 19590176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acrosome staining and motility characteristics of sterlet spermatozoa after cryopreservation with use of methanol and DMSO.
    Psenicka M; Dietrich GJ; Wojtczak M; Nynca J; Rodina M; Linhart O; Cosson J; Ciereszko A
    Cryobiology; 2008 Jun; 56(3):251-3. PubMed ID: 18466892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion.
    Júnior AM; Arrais CA; Saboya R; Velasques RD; Junqueira PL; Dulley FL
    Bone Marrow Transplant; 2008 Jan; 41(1):95-6. PubMed ID: 17934528
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma.
    Hiwase DK; Bollard G; Hiwase S; Bailey M; Muirhead J; Schwarer AP
    Cytotherapy; 2007; 9(6):539-47. PubMed ID: 17882718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
    Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
    Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.